You have 9 free searches left this month | to do more
Showing 1 - 25 of
4,101 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2
Recruiting
  • Thrombocythemia, Essential
  • San Antonio, Texas
    Mays Cancer Center
2021-12-14
Dec 14, 2021
U
Arterial Function and Atherosclerosis in Essential Thrombocythemia - 2021
Completed
Has Results
  • Atherosclerosis
  • imaging
  • (no location specified)
2021-10-06
Oct 6, 2021
I
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia
Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
2022-03-25
Mar 25, 2022
I
Extension Study of Bomedemstat (IMG-7289) in Patients With Myeloproliferative Neoplasms
Recruiting
  • Thrombocythemia, Essential
  • Primary Myelofibrosis
  • Hong Kong, Hong Kong
    Queen Mary Hospital
2022-01-24
Jan 24, 2022
T
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
Recruiting
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Miami, Florida
    University of Miami
2021-09-23
Sep 23, 2021
D
Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure - 2020
Completed
  • Polycythemia Vera
  • Thrombocythemia, Essential
  • No cytoreductive vs cytoreductive drugs
  • Geneva, Switzerland
  • +1 more
2020-11-09
Nov 9, 2020
U
CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia
Recruiting
  • CALR Gene Mutation
  • +5 more
  • Continuous Positive Airway Pressure
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
2022-03-01
Mar 1, 2022
F
The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line - 2021
Terminated
  • Essential Thrombocythemia
  • Tours, France
    FILO
2021-06-28
Jun 28, 2021
U
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Active, not recruiting
  • Myeloproliferative Neoplasm
  • +4 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
2022-01-20
Jan 20, 2022
M
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
Not yet recruiting
  • Myelofibrosis
  • +2 more
  • Peptide-based vaccine
  • Poly ICLC
  • New York, New York
    Icahn School of Medicine at Mount Sinai
2021-08-24
Aug 24, 2021
M
Ruxolitinib in Thrombocythemia and Polycythemia Vera
Not yet recruiting
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Boston, Massachusetts
  • +2 more
2020-11-24
Nov 24, 2020
S
The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) - 2008
Completed
Has Results
  • Essential Thrombocythaemia
  • anagrelide hydrochloride
  • Barcelona, Spain
  • +4 more
2021-06-07
Jun 7, 2021
N
Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis
Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
2021-11-05
Nov 5, 2021
N
A Prospective, Two-arm, Non-interventional Study of JAKAVI® (Ruxolitinib) in Patients With Myelofibrosis
Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
2021-09-06
Sep 6, 2021
U
Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
Not yet recruiting
  • Myeloproliferative Neoplasm
  • +3 more
  • CALR allele burden quantification
  • (no location specified)
2021-06-18
Jun 18, 2021
J
MPN-RC 118 AVID200 in Myelofibrosis
Active, not recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
2021-05-19
May 19, 2021
M
Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis
Recruiting
  • Myelofibrosis Transformation in Essential Thrombocythemia
  • +2 more
  • Elotuzumab
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
2021-02-17
Feb 17, 2021
H
18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia
Unknown status
  • Essential Thrombocythemia
  • +2 more
  • Diagnostic (18F-FLT PET/CT)
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
2020-09-27
Sep 27, 2020
L
A Study of LNK01002 in Patients With Primary (PMF) or Secondary Myelofibrosis (PV-MF, ET-MF) or Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Farmington Hills, Michigan
  • +1 more
2021-06-05
Jun 5, 2021
U
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
2021-09-27
Sep 27, 2021
S
Jaktinib Hydrochloride for the Treatment of Ruxolitinib Intolerance of Myelofibrosis
Recruiting
  • Myelofibrosis
  • +3 more
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
2021-06-11
Jun 11, 2021
S
Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia - 2018
Completed
Has Results
  • Primary Myelofibrosis
  • +4 more
  • Scottsdale, Arizona
  • +21 more
2021-01-18
Jan 18, 2021
N
Study of Select Combinations in Adults With Myelofibrosis
Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
2021-03-02
Mar 2, 2021
M
LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis
Active, not recruiting
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-08
Nov 8, 2021
M
Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm
Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-30
Oct 30, 2021